Barry P. Flannelly - 07 Jun 2023 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Mary Grendell, Attorney-in-fact
Issuer symbol
TARA
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
08 Jun 2023, 16:10:36 UTC
Previous filing
24 Jan 2023
Next filing
06 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 07 Jun 2023 Common Stock 10,000 $2.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.

Remarks:

Exhibit 24.1 - Power of Attorney